SEC Form 4 · accession 0001674752-17-000002
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Emerson Jorden
Officer — CEO, CFO · Director · 10% Owner
Period of report
Aug 10, 2017
Accepted (ET)
Aug 14, 2017 · 3:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Aug 10, 2017 | P | 247,500 | $0.2222 | A | 557,146 | D | |
| COMMON STOCK | holding | — | — | — | 190 | I | BY CHILDREN |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes shares held jointly with spouse and shares held in IRA.